INFORMATION ON THE ADVISORY OF AMGROS IMPLEMENTATION ASSETS ON COMMITTEE LEGISLATION IN 2025 Q3 Text automatically translated in your browsing language Automatically translated

This prior notification is an indication of Amgros’ expected conclusion of commissioning agreements for covered medicinal products in Section 3.1. Amgros will enter into commissioning agreements with all interested parties, and Amgros therefore invites anyone who potentially wants to enter into Amgros' commissioning agreements for the medicines below to express interest by sending relevant information including price to kontakt@amgros.dk. Amgros expects at a later stage to offer the covered medicinal products as offered framework agreements on public tenders, and the expectation is that the tender will be published within the next 12 months, but this will depend on several factors. Even when the tender is published, Amgros will continue to conclude commissioning agreements on standard terms with interested parties, but it will not be possible to negotiate terms, including the price of the commissioning agreement, from then on. The final terms of the tenders will be set out in the tender documents when they are published. In relation to the section 'Information about the notice', it should be noted that the contract notice for the medicinal products covered will be published when the call for tenders is published, and that the date in the section is only indicative. Text automatically translated in your browsing language Automatically translated

33600000 - Pharmaceutical products